These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9555058)

  • 1. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning.
    David S; Shoemaker M; Haley BE
    Brain Res Mol Brain Res; 1998 Mar; 54(2):276-87. PubMed ID: 9555058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP nucleotidylation of creatine kinase.
    David SS; Haley BE
    Biochemistry; 1999 Jun; 38(26):8492-500. PubMed ID: 10387096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labeling of creatine kinase with 2-azido- and 8-azidoadenosine triphosphate: identification of two peptides from the ATP-binding domain.
    Olcott MC; Bradley ML; Haley BE
    Biochemistry; 1994 Oct; 33(39):11935-41. PubMed ID: 7918412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
    Aksenov M; Aksenova M; Butterfield DA; Markesbery WR
    J Neurochem; 2000 Jun; 74(6):2520-7. PubMed ID: 10820214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanosine triphosphate binding to beta-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau.
    Khatoon S; Grundke-Iqbal I; Iqbal K
    J Neurochem; 1995 Feb; 64(2):777-87. PubMed ID: 7830071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant casein kinase II in Alzheimer's disease.
    Iimoto DS; Masliah E; DeTeresa R; Terry RD; Saitoh T
    Brain Res; 1990 Jan; 507(2):273-80. PubMed ID: 2337767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.
    Aksenov MY; Aksenova MV; Payne RM; Smith CD; Markesbery WR; Carney JM
    Exp Neurol; 1997 Aug; 146(2):458-65. PubMed ID: 9270056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophosphorylation of creatine kinase: characterization and identification of a specifically phosphorylated peptide.
    Hemmer W; Furter-Graves EM; Frank G; Wallimann T; Furter R
    Biochim Biophys Acta; 1995 Sep; 1251(2):81-90. PubMed ID: 7669815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location and regulation of octameric mitochondrial creatine kinase in the contact sites.
    Kottke M; Adams V; Wallimann T; Nalam VK; Brdiczka D
    Biochim Biophys Acta; 1991 Jan; 1061(2):215-25. PubMed ID: 1998693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain isoform of a key ATP-regulating enzyme, creatine kinase, is a phosphoprotein.
    Mahadevan LC; Whatley SA; Leung TK; Lim L
    Biochem J; 1984 Aug; 222(1):139-44. PubMed ID: 6477506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.
    Aksenova MV; Aksenov MY; Payne RM; Trojanowski JQ; Schmidt ML; Carney JM; Butterfield DA; Markesbery WR
    Dement Geriatr Cogn Disord; 1999; 10(2):158-65. PubMed ID: 10026391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant guanosine triphosphate-beta-tubulin interaction in Alzheimer's disease.
    Khatoon S; Campbell SR; Haley BE; Slevin JT
    Ann Neurol; 1989 Aug; 26(2):210-5. PubMed ID: 2774507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of brain-type creatine kinase at 1.41 A resolution.
    Eder M; Schlattner U; Becker A; Wallimann T; Kabsch W; Fritz-Wolf K
    Protein Sci; 1999 Nov; 8(11):2258-69. PubMed ID: 10595529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain isoforms of creatine kinase in health and mental diseases: Alzheimer's disease and schizophrenia].
    Burbaeva GSh; Savushkina OK; Dmitriev AD
    Vestn Ross Akad Med Nauk; 1999; (1):20-4. PubMed ID: 10078058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide- and Ca2+-independent phosphorylation of tubulin and microtubule-associated protein-2 by glycogen synthase (casein) kinase-1.
    Singh TJ; Akatsuka A; Huang KP; Murthy AS; Flavin M
    Biochem Biophys Res Commun; 1984 May; 121(1):19-26. PubMed ID: 6329194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease.
    Saitoh T; Iimoto D
    Prog Clin Biol Res; 1989; 317():769-80. PubMed ID: 2690121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and application of bidentate photoaffinity cross-linking reagents. Nucleotide photoaffinity probes with two photoactive groups.
    Rajagopalan K; Chavan AJ; Haley BE; Watt DS
    J Biol Chem; 1993 Jul; 268(19):14230-8. PubMed ID: 8314786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP-binding and ATP-binding sites in native and proteinase-K-digested creatine kinase, probed by reaction-induced difference infrared spectroscopy.
    Raimbault C; Clottes E; Leydier C; Vial C; Buchet R
    Eur J Biochem; 1997 Aug; 247(3):1197-208. PubMed ID: 9288948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of adenine binding domain peptides of the NADP+ active site within porcine heart NADP(+)-dependent isocitrate dehydrogenase.
    Sankaran B; Chavan AJ; Haley BE
    Biochemistry; 1996 Oct; 35(42):13501-10. PubMed ID: 8885829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.